Arcadia Biosciences, Inc. (RKDA) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Arcadia Biosciences, Inc. (RKDA) operates in the Basic Materials sector, specifically the Agricultural Inputs industry, with a market capitalization near $1.4M, listed on NASDAQ, employing roughly 9 people, carrying a beta of 0.52 to the broader market. Arcadia Biosciences, Inc. Led by Thomas J. Schaefer, public since 2015-05-15.

Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for RKDA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how max pain is reported and how to read the data →